Oxygen Therapy in Patients With Chronic Heart Failure With Reduced Ejection Fraction

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The purpose of this study is to assess patients with chronic heart failure and moderate-severe ventricular dysfunction (left ventricular ejection fraction (FEVE) \<40%) with nocturnal desaturation (mean Oxygen saturation (SatO2) \<90% and/or Cummulative time (TC) \<90% \> 22 minutes) without underlying respiratory disease, oxygen treatment during hours of night rest will reduce exacerbations, improve the ability to effort, sleep quality and poor prognostic parameters of heart failure, compared to patients not receiving oxygen treatment.
Epistemonikos ID: 8ff32d0b68a03624402f103c25bf99f4642232e2
First added on: May 15, 2024